FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 56 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,022,000,000 | +49553.9% | 2,110,071 | -21.8% | 0.56% | -44.3% |
Q1 2019 | $10,114,000 | -30.4% | 2,697,133 | -33.4% | 1.00% | -45.5% |
Q4 2018 | $14,531,000 | -37.1% | 4,047,561 | +0.4% | 1.84% | -49.0% |
Q3 2018 | $23,094,000 | -3.6% | 4,030,268 | -15.7% | 3.60% | +8.4% |
Q2 2018 | $23,956,000 | -99.9% | 4,781,708 | 0.0% | 3.32% | -8.9% |
Q1 2018 | $24,530,000,000 | +85257.4% | 4,781,708 | 0.0% | 3.64% | -25.7% |
Q4 2017 | $28,738,000 | +8.3% | 4,781,708 | 0.0% | 4.90% | -5.0% |
Q3 2017 | $26,538,000 | +19.6% | 4,781,708 | 0.0% | 5.16% | +29.9% |
Q2 2017 | $22,187,000 | +21.7% | 4,781,708 | +29.9% | 3.98% | +9.8% |
Q1 2017 | $18,224,000 | -45.3% | 3,681,708 | +22.7% | 3.62% | -47.1% |
Q4 2016 | $33,300,000 | +29.8% | 3,000,000 | +8.3% | 6.84% | +4.6% |
Q3 2016 | $25,645,000 | +1369.6% | 2,769,425 | +908.0% | 6.54% | +1208.2% |
Q2 2016 | $1,745,000 | – | 274,756 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,000,000 | $7,330,000 | 3.56% |
Sio Capital Management, LLC | 336,286 | $2,465,000 | 1.69% |
Opaleye Management Inc. | 285,000 | $2,089,000 | 1.03% |
SENZAR ASSET MANAGEMENT, LLC | 864,408 | $6,336,111,000 | 0.92% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,350,847 | $9,902,000 | 0.74% |
Ghost Tree Capital, LLC | 150,000 | $1,100,000 | 0.50% |
PURA VIDA INVESTMENTS, LLC | 102,000 | $748,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 380,000 | $2,785,000 | 0.36% |
J. Goldman & Co LP | 474,810 | $3,480,000 | 0.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 948,934 | $6,956,000 | 0.27% |